Foldax Inc. has officially launched its TRIA™ Mitral Valve in India, marking the world’s first polymer heart valve to...
Read moreFoldax Inc. is sharing compelling one-year results from India’s clinical trial of the TRIA Mitral Valve, showing a good...
Read moreFoldax® Inc. announced compelling one-year results from the India Clinical Trial of the TRIA™ Mitral Valve, showing a good...
Read moreFoldax Inc. announced that the Indian Central Drugs Standard Control Organization (CDSCO) approved its TRIA™ Mitral Valve. Dolphin Life...
Read moreFoldax is targeting India for the first approval of its polymer mitral surgical heart valve. The company spoke with...
Read moreFoldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a...
Read moreFoldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have...
Read moreFoldax® Inc., a pioneer in the development of innovative, polymer heart valves, today announced a manufacturing agreement with Dolphin...
Read moreFoldax announced completion of enrollment in the Indian clinical trial of the TRIA™ polymer surgical mitral heart valve.
Read moreFoldax announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial...
Read more